当前位置:首页 >财报库 > 报告详情

默克集团Merck Group(MRK)2025年年度财报「FWB」(英文版)(359页).pdf

上传人: 1****1 编号:1155333 2026-03-12 359页 5.66MB

下载:

1、Annual Financial Statements2025 Table of contents Combined Management Report 4 Fundamental Information about the Group 4 Company Profile and Structure 15 Strategy 22 Internal Management System 29 Research and Development 41 Report on Economic Position 41 Macroeconomic and Sector-Specific Environment

2、 45 Review of Forecast against Actual Business Development 49 Course of Business and Economic Position 49 Merck Group 60 Life Science 64 Healthcare 69 Electronics 73 Corporate and Other 74 Report on Risks and Opportunities 94 Report on Expected Developments 97 Report in accordance with section 315a

3、of the German Commercial Code(HGB)100 Sustainability Statement 101 General 133 Environment 203 Social 271 Governance 292 Additional Information on Merck KGaA in accordance with the German Commercial Code(HGB)Annual Financial Statements 298 Income Statement for the Period from January 1 to December 3

4、1,2024 299 Balance Sheet as of December 31,2024 300 Notes for the Fiscal Year 2024 300 General Disclosures 301 Notes to the Income Statement 305 Notes to the Balance Sheet 315 Other Disclosures 320 Members of the Executive Board of Merck KGaA 321 Members of the Supervisory Board of Merck KGaA 323 No

5、tification of voting rights in accordance with section 160(1)no.8 of the German Stock Corporation Act(AktG)324 List of Shareholdings of Merck KGaA as of December 31,2024 343 Reproduction of the Independent Auditors Report 351 Responsibility Statement in Accordance with Section 264(2)Sentence 3 HGB a

6、nd Section 289(1)Sentence 5 HGB 352 Report of the Supervisory Board 358 Financial Calendar Combined Management Reporta 4 Fundamental Information about the Group 4 Company Profile and Structure 15 Strategy 22 Internal Management System 29 Research and Development 41 Report on Economic Position 41 Mac

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
1. **公司概况**:Merck KGaA成立于1668年,为全球科学和技术公司,业务覆盖生命科学(Life Science)、医疗保健(Healthcare)和电子(Electronics)三大领域,愿景为“Sparking Discovery, Elevating Humanity”。 2. **财务表现**:2025年,生命科学占集团销售额42%,医疗保健占41%,电子占17%;生命科学和医疗保健分别贡献集团EBITDA pre(未计公司及其他)的40%和47%。 3. **业务亮点**: - **生命科学**:通过收购Hub Organoids强化下一代生物学领域,与西门子合作开发端到端数字工作流。 - **医疗保健**:收购SpringWorks Therapeutics成立罕见病业务,Ogsiveo®和Gomekli®/Ezmekly®贡献销售额1.89亿欧元;Erbitux®销售额11.76亿欧元,Mavenclad®达11.94亿欧元。 - **电子**:半导体解决方案业务聚焦AI和高性能芯片,台湾高雄新厂投产,占电子销售额72%。 4. **战略重点**:创新驱动增长,加强研发投入,通过并购优化业务组合(如剥离Surface Solutions),目标2040年实现气候中和。
**Merck战略亮点?** **生命科学新突破?** **医疗领域增长点?**
客服
商务合作
小程序
服务号
折叠